ABCG2 and metabolic syndrome: ABCG2 34GA genotype was likely to be associated with impaired triglyceride level with marginal significance and have been shown an increased risk for dyslipidemia (P = 0.07, OR = 2.76) when compared between impaired triglyceride level and normal triglyceride level among patients without HIVLD.